Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Novo Integrated Sciences, Inc. (NVOS)
Bellevue, WA, US
Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary healthcare services and related products through its two primary operational segments: Healthcare Services and Product Manufacturing and Development. The company's extensive service portfolio includes various therapeutic approaches such as physiotherapy, chiropractic care, manual manipulation, occupational therapy, and massage therapy. They also offer specialized treatments like acupuncture, functional dry needling, chiropody, and advanced rehabilitation for stroke, traumatic brain injuries, and other neurological conditions. Additionally, NVOS provides kinesiology, vestibular therapy, concussion management, and baseline testing, alongside unique programs like trauma-sensitive yoga and meditation for brain injury recovery and PTSD. Women's pelvic health, sports medicine, assistive device provision, dietetics, holistic nutrition, fall prevention education, sports team conditioning, and private personal training are also part of their offerings. Novo Integrated Sciences, Inc. is dedicated to the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of a wide range of orthopedic, musculoskeletal, sports injury, and neurological conditions. These services are provided across all age demographics, from pediatric and adult patients to geriatric populations. For older adults, the company offers comprehensive eldercare physiotherapy within long-term care homes, retirement communities, and through community-based home care. This includes group exercise classes and fall prevention initiatives, alongside services at outpatient clinics. Similarly, occupational therapy services for the elderly are extended to retirement communities and long-term care facilities. Beyond direct care, the company incorporates medical technology, offering telemedicine consultations and remote patient monitoring. It also actively develops and distributes bespoke health and wellness product solutions. NVOS operates a network of 16 wholly-owned clinics. Established in 2000, the company is headquartered in Bellevue, Washington, and operates as a subsidiary of ALMC-ASAP Holdings, Inc.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +545.16% | +545.16% | +545.16% | +1,900.00% | +640.74% | +233.33% | -98.48% | -99.91% | -99.50% | -99.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Care Facilities: +10.2%+5.8% Q3'24: -6.7% (vs Q3'23)
-
EPS growth Medical - Care Facilities: +19.2%+30.8% ★ Q3'24: +230.0% (vs Q3'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-80.3% Q3'24: -17.8% (vs Q3'23)
-
EBIT margin Medical - Care Facilities: +11.3%-126.2% Q3'24: +217.0% (vs Q3'23)
-
ROIC Medical - Care Facilities: +6.8%-90.8% Q3'24: +144.7% (vs Q3'23)
-
Share dilution Medical - Care Facilities: +0.0%+77.4% Q3'24: +20.9% (vs Q3'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×-0.47× Q3'24: 0.16× (vs Q3'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hudson Bay Capital Management LP | 3.18M | 9.99% | — | 3.18M | — | — | PN | State of Delaware | 2022-02-08 | ↗ |
| 2 | Sander Gerber | 3.18M | 9.99% | — | 3.18M | — | — | IN | United States | 2022-02-08 | ↗ |
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-31 | David Christopher Mehlin | Director / Officer | A-Award | A | Stock Option (right to buy) | 2,000,000 | 0.13 | 264.0K | 2,000,000 | — | ↗ |
| 2022-08-09 | Ali Sarfaraz | Director | A-Award | A | Stock Option (right to buy) | 39,480 | 0.00 | — | 39,480 | — | ↗ |
| 2022-06-30 | Ali Sarfaraz | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-04-19 | Oliva Robert Letterio | Director | P-Purchase | A | Common Stock | 300 | 2.25 | 675.00 | 217,717 | — | ↗ |
| 2022-02-23 | Pope Michael Ross | Director | A-Award | A | Stock option(right to buy) | 93,995 | 1.33 | 125.0K | 93,995 | — | ↗ |
| 2022-02-23 | Oliva Robert Letterio | Director | A-Award | A | Stock Option (right to buy) | 93,995 | 1.33 | 125.0K | 93,995 | — | ↗ |
| 2022-02-23 | Flesias Alex | Director | A-Award | A | Stock Option (right to buy) | 93,995 | 1.33 | 125.0K | 93,995 | — | ↗ |
| 2021-04-21 | Oliva Robert Letterio | Director | P-Purchase | A | Common Stock | 13,000 | 2.12 | 27.6K | 207,717 | — | ↗ |
| 2021-04-20 | Jimenez Sterling M. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-02-23 | Oliva Robert Letterio | Director | P-Purchase | A | Common Stock | 200 | 4.45 | 890.00 | 194,717 | — | ↗ |
| 2021-02-22 | Oliva Robert Letterio | Director | P-Purchase | A | Common Stock | 9,355 | 4.31 | 40.3K | 194,517 | — | ↗ |
| 2021-02-19 | Oliva Robert Letterio | Director | — | — | Common Stock | 0 | 0.00 | — | 178,555 | D | ↗ |
| 2021-02-19 | Mattacchione Robert | Director / Officer / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 12,908,562 | — | ↗ |
| 2021-02-19 | Gaynor Michael Joseph | Director | — | I | Common Stock | 0 | 0.00 | — | 1,743,713 | — | ↗ |
| 2021-02-19 | David Christopher Mehlin | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 81,950 | — | ↗ |
| 2021-02-19 | Dalcourt Pierre Joseph | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 3,387,794 | — | ↗ |
| 2021-02-19 | BRAY THOMAS EDWARD | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Pope Michael Ross | Director | — | D | Stock Option (right to buy) | 33,000 | 3.80 | 125.4K | 0 | — | ↗ |
| 2021-01-26 | Oliva Robert Letterio | Director | — | — | Stock Option (right to buy) | 19,800 | 3.80 | 75.2K | 0 | D | ↗ |
| 2021-01-26 | Flesias Alex | Director | — | D | Stock Option (right to buy) | 19,800 | 3.80 | 75.2K | 0 | — | ↗ |
| 2020-08-06 | David Christopher Mehlin | Director / Officer | — | D | Stock Option (right to buy) | 575,000 | 3.00 | 1.73M | 0 | — | ↗ |
| 2017-12-29 | David Christopher Mehlin | Director / Officer | — | D | Stock Option (right to buy) | 200,000 | 1.60 | 320.0K | 0 | — | ↗ |
| 2017-05-03 | Mattacchione Robert | Director / Officer / 10% Owner | — | I | Stock Option (right to buy) | 25,000 | 1.60 | 40.0K | 0 | — | ↗ |
| 2017-04-28 | Oliva Robert Letterio | Director | — | — | Stock Option (right to buy) | 25,000 | 1.60 | 40.0K | 0 | D | ↗ |
| 2007-11-12 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 5,000 | 0.66 | 3.3K | 5,058,963 | — | ↗ |
| 2007-11-06 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 700 | 1.30 | 910.00 | 5,063,963 | — | ↗ |
| 2007-11-05 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.25 | 6.3K | 5,064,663 | — | ↗ |
| 2007-11-01 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 6,000 | 1.46 | 8.8K | 5,069,663 | — | ↗ |
| 2007-10-30 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.41 | 7.0K | 5,075,663 | — | ↗ |
| 2007-10-29 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 20,000 | 1.37 | 27.5K | 5,080,663 | — | ↗ |
| 2007-10-24 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 9,500 | 1.44 | 13.7K | 4,800,055 | — | ↗ |
| 2007-10-23 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.35 | 13.5K | 4,809,555 | — | ↗ |
| 2007-10-23 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.40 | 14.0K | 5,100,663 | — | ↗ |
| 2007-01-31 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 10,000 | 0.45 | 4.5K | 5,130,663 | — | ↗ |
| 2007-01-30 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 16,310 | 0.46 | 7.5K | 5,140,663 | — | ↗ |
| 2007-01-29 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 17,345 | 0.51 | 8.8K | 5,156,973 | — | ↗ |
| 2007-01-26 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 12,500 | 0.54 | 6.7K | 5,174,318 | — | ↗ |
| 2006-12-18 | ROUSE MICHAEL | Officer / 10% Owner | P-Purchase | D | Common Stock | 2,833 | 0.60 | 1.7K | 4,819,555 | — | ↗ |
| 2006-11-03 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 1,000 | 0.71 | 710.00 | 4,816,722 | — | ↗ |
| 2006-10-31 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 1,500 | 0.71 | 1.1K | 4,817,722 | — | ↗ |
| 2006-10-03 | Alpha Engines, Corp. | 10% Owner | P-Purchase | A | Common Stock | 100,000 | 61,000.00 | 6.10B | 5,186,818 | — | ↗ |
| 2006-08-14 | ROUSE MICHAEL | Officer / 10% Owner | P-Purchase | A | Common Stock | 111,295 | 94,601.51 | 10.53B | 4,819,222 | — | ↗ |
| 2006-07-14 | Alpha Engines, Corp. | 10% Owner | P-Purchase | A | Common Stock | 13,958 | 11,864.76 | 165.61M | 5,086,818 | — | ↗ |
| 2006-06-21 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 1,000 | 1.57 | 1.6K | 4,707,927 | — | ↗ |
| 2006-06-21 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 6,600 | 1.43 | 9.4K | 5,072,860 | — | ↗ |
| 2006-06-19 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.22 | 12.2K | 4,708,927 | — | ↗ |
| 2006-05-17 | Alpha Engines, Corp. | 10% Owner | S-Sale | D | Common Stock | 4,300 | 1.10 | 4.7K | 5,079,460 | — | ↗ |
| 2006-05-12 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 1,000 | 1.68 | 1.7K | 4,718,927 | — | ↗ |
| 2006-05-09 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 2,000 | 1.68 | 3.4K | 4,719,927 | — | ↗ |
| 2006-05-08 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.44 | 14.4K | 4,721,927 | — | ↗ |
| 2006-05-05 | ROUSE MICHAEL | Officer / 10% Owner | P-Purchase | D | Common Stock | 500 | 1.44 | 720.00 | 4,731,927 | — | ↗ |
| 2006-05-04 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 3,000 | 1.20 | 3.6K | 4,733,427 | — | ↗ |
| 2006-05-03 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 2,000 | 1.20 | 2.4K | 4,736,427 | — | ↗ |
| 2006-05-01 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.03 | 10.3K | 4,738,427 | — | ↗ |
| 2006-04-28 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 2,300 | 1.10 | 2.5K | 4,749,627 | — | ↗ |
| 2006-04-27 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 29,000 | 1.05 | 30.5K | 4,752,427 | — | ↗ |
| 2006-04-26 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 19,500 | 1.05 | 20.5K | 4,782,427 | — | ↗ |
| 2006-04-25 | ROUSE MICHAEL | Officer / 10% Owner | S-Sale | D | Common Stock | 100 | 1.78 | 178.00 | 4,801,927 | — | ↗ |
| 2005-12-31 | ROUSE MICHAEL | Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-12-31 | Alpha Engines, Corp. | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2005-08-25 | McDonald Rebecca AW | Officer | — | D | Common Stock | 0 | 0.00 | — | 20,000 | — | ↗ |
| 2004-08-12 | TETERS JAMES JR | Director | — | D | Common Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2004-08-12 | ROUSE PHYLLIS | Officer | — | D | Common Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
| 2004-08-12 | ROUSE MICHAEL | Officer | — | D | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2004-08-12 | HILDEN JAY | Officer | — | D | Common Stock | 0 | 0.00 | — | 110,000 | — | ↗ |
| 2004-08-12 | Cox David M | Officer | — | D | Common Stock | 0 | 0.00 | — | 80,000 | — | ↗ |
| 2004-08-12 | Alpha Engines, Corp. | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2004-08-12 | Adamo Robert | Director | — | D | Common Stock | 0 | 0.00 | — | 100,000 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Christopher David Chief Operating Officer | 171.0K | — | — | 263.6K | — | — | 434.6K | 60.65% | ↗ |
| 2 | 2024 | Robert Mattacchione Chief Executive Officer | 185.0K | — | — | — | — | — | 185.0K | 0.00% | ↗ |
| 3 | 2023 | Christopher David Chief Operating Officer | 171.0K | — | — | 156.0K | — | — | 327.0K | 47.71% | ↗ |
| 4 | 2023 | Robert Mattacchione Chief Executive Officer | 185.0K | — | — | — | — | — | 185.0K | 0.00% | ↗ |
| 5 | 2022 | Robert Mattacchione Chief Executive Officer | 185.0K | — | — | — | — | — | 185.0K | 0.00% | ↗ |
| 6 | 2021 | Christopher David COO-President | 171.0K | — | — | — | — | — | 171.0K | 0.00% | ↗ |
| 7 | 2021 | Robert Mattacchione Chief Executive Officer | 46.5K | — | — | — | — | — | 46.5K | 0.00% | ↗ |
| 8 | 2020 | Christopher David COO-President | 114.8K | — | — | — | — | — | 114.8K | 0.00% | ↗ |
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert Mattacchione | Chairman of the Board & Chief Executive Officer | 185.0K | male |
| Christopher Mehlin David | Chief Operating Officer & Director | 171.0K | male |
| Joseph Chalil FACHE | Chief Medical Officer | — | — |
| Vivek Sethi | Principal Financial Officer & Principal Accounting Officer | — | male |
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NVOS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
